ISSN: 2167-7948
+44 1300 500008
Department of Endocrinology, Yamashita Thyroid Hospital, 1-8 Shimogofukumachi, Hakata-ku, Fukuoka City, Japan
Research Article
Changes in Thyroid Stimulating Antibody Levels in Graves' Disease Patients: Methods to Prevent its Increase after Radioactive Iodine Therapy
Author(s): Seigo Tachibana*, Tomohiro Ohsako, Yusuke Mori, Hisakazu Shindo, Shinya Satoh, Hiroshi Takahashi and Hiroyuki Yamashita
Background: Although it is well-known that thyroid stimulating antibody levels usually increase after radioactive
iodine therapy, we observed various changes in thyroid stimulating antibody levels.
Methods: We divided 47 patients who underwent radioactive iodine therapy into two groups based on thyroid
stimulating antibody levels three months post-therapy, as follows: the D(3M) group with increasing levels and the
I(3M) group with decreasing levels of the antibody. We compared the clinical characteristics of the two groups.
In addition, the 47 patients were again divided into the following two groups, and their clinical characteristics
were compared: the D(6M) and I(6M) groups, which consisted of patients with decreasing and increasing thyroid
stimulating antibody levels, respectively, three to six months after radioactive io.. View More»
DOI:
10.35248/2167-7948.20.9.241